Cronos Group Inc (NASDAQ:CRON) shares traded -4.10% lower at $1.87 on Wall Street last session.
In accordance with the data, 8 analysts cover Cronos Group Inc (NASDAQ:CRON). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $3.62 and a low of $1.78, we find $2.41. Given the previous closing price of $1.95, this indicates a potential upside of 23.59 percent. CRON stock price is now -6.23% away from the 50-day moving average and -3.64% away from the 200-day moving average. The market capitalization of the company currently stands at $712.68M.
It has been rated a hold by 4 analysts and a buy by 3. Brokers who have rated the stock have averaged $2.51 as their price target over the next twelve months.
With the price target of $3, Bernstein recently initiated with Mkt Perform rating for Cronos Group Inc (NASDAQ: CRON).
In other news, ADLER JASON MARC, Director bought 37,500 shares of the company’s stock on May 30. The stock was bought for $65,074 at an average price of $1.74. Upon completion of the transaction, the Director now directly owns 1,402,304 shares in the company, valued at $2.62 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 25, Director ADLER JASON MARC bought 100,000 shares of the business’s stock. A total of $179,650 was incurred on buying the stock at an average price of $1.80. This leaves the insider owning 1,376,054 shares of the company worth $2.57 million. Insiders disposed of 230,282 shares of company stock worth roughly $0.43 million over the past 1 year. A total of 47.93% of the company’s stock is owned by insiders.
Cronos Group Inc (NASDAQ: CRON) opened at $1.9600 on Thursday. During the past 12 months, Cronos Group Inc has had a low of $1.64 and a high of $3.62. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 30.03, and a quick ratio of 28.86. The fifty day moving average price for CRON is $1.9942 and a two-hundred day moving average price translates $1.9406 for the stock.
The latest earnings results from Cronos Group Inc (NASDAQ: CRON) was released for Sep, 2023. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at $0, beating analysts’ expectations of -$0.02 by 0.02. This compares to -$0.01 EPS in the same period last year. The net profit margin was -124.25% and return on equity was -9.08% for CRON. The company reported revenue of $24.81 million for the quarter, compared to $20.41 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 21.56 percent. For the current quarter, analysts expect CRON to generate $25.39M in revenue.
Cronos Group Inc(CRON) Company Profile
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.